Amgen (AMGN)
(Delayed Data from NSDQ)
$273.01 USD
-0.53 (-0.19%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $275.01 +2.00 (0.73%) 7:38 PM ET
3-Hold of 5 3
C Value D Growth F Momentum D VGM
Balance Sheet
Fiscal Year End for Amgen Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 10,944 | 9,305 | 8,037 | 10,647 | 8,911 |
Receivables | 7,268 | 5,563 | 4,895 | 4,525 | 4,057 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 9,518 | 4,930 | 4,086 | 3,893 | 3,584 |
Other Current Assets | 2,602 | 2,388 | 2,367 | 2,079 | 1,888 |
Total Current Assets | 30,332 | 22,186 | 19,385 | 21,144 | 18,440 |
Net Property & Equipment | 5,941 | 5,427 | 5,184 | 4,889 | 4,928 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 51,270 | 31,609 | 30,072 | 31,276 | 34,116 |
Deposits & Other Assets | 9,611 | 5,899 | 6,524 | 5,639 | 2,223 |
Total Assets | 97,154 | 65,121 | 61,165 | 62,948 | 59,707 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 1,590 | 1,572 | 1,366 | 1,421 | 1,371 |
Current Portion Long-Term Debt | 1,443 | 1,591 | 87 | 91 | 2,953 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 15,359 | 12,524 | 10,731 | 10,141 | 8,511 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 18,392 | 15,687 | 12,184 | 11,653 | 12,835 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 2,354 | 0 | 0 | 0 | 606 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 63,170 | 37,354 | 33,222 | 32,895 | 26,950 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 7,006 | 8,419 | 9,059 | 8,991 | 9,643 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 90,922 | 61,460 | 54,465 | 53,539 | 50,034 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 33,070 | 32,514 | 32,096 | 31,802 | 31,531 |
Capital Surplus | 0 | 0 | 0 | 0 | 0 |
Retained Earnings | -26,549 | -28,622 | -24,600 | -21,408 | -21,330 |
Other Equity | -289 | -231 | -796 | -985 | -528 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 6,232 | 3,661 | 6,700 | 9,409 | 9,673 |
Total Liabilities & Shareholder's Equity | 97,154 | 65,121 | 61,165 | 62,948 | 59,707 |
Total Common Equity | 6,232 | 3,661 | 6,700 | 9,409 | 9,673 |
Shares Outstanding | 535.10 | 533.50 | 558.30 | 582.10 | 594.10 |
Book Value Per Share | 11.65 | 6.86 | 12.00 | 16.16 | 16.28 |
Fiscal Year End for Amgen Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 10,944 | 34,741 | 34,248 | 31,561 |
Receivables | NA | 7,268 | 6,145 | 5,830 | 5,736 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 9,518 | 5,026 | 4,978 | 5,011 |
Other Current Assets | NA | 2,602 | 2,565 | 2,324 | 2,395 |
Total Current Assets | NA | 30,332 | 48,477 | 47,380 | 44,703 |
Net Property & Equipment | NA | 5,941 | 5,563 | 5,532 | 5,460 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 51,270 | 28,659 | 30,164 | 30,924 |
Deposits & Other Assets | NA | 9,611 | 7,835 | 7,193 | 7,633 |
Total Assets | NA | 97,154 | 90,534 | 90,269 | 88,720 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 1,590 | 1,358 | 1,212 | 1,320 |
Current Portion Long-Term Debt | NA | 1,443 | 1,428 | 2,167 | 834 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 15,359 | 14,168 | 13,718 | 12,061 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 0 | 0 | 0 | 0 |
Total Current Liabilities | NA | 18,392 | 16,954 | 17,097 | 14,215 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 2,354 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 63,170 | 59,040 | 59,377 | 60,761 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 6,884 | 7,014 | 8,396 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 90,922 | 82,878 | 83,488 | 83,372 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 33,070 | 32,753 | 32,601 | 32,535 |
Capital Surplus | NA | 0 | 0 | 0 | 0 |
Retained Earnings | NA | -26,549 | -24,971 | -25,540 | -26,919 |
Other Equity | NA | -289 | -126 | -280 | -268 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 6,232 | 7,656 | 6,781 | 5,348 |
Total Liabilities & Shareholder's Equity | NA | 97,154 | 90,534 | 90,269 | 88,720 |
Total Common Equity | 0 | 6,232 | 7,656 | 6,781 | 5,348 |
Shares Outstanding | 535.90 | 535.10 | 535.10 | 534.30 | 534.30 |
Book Value Per Share | 0.00 | 11.65 | 14.31 | 12.69 | 10.01 |